Past event
March 2024 Prescription Drug Affordability Board Meeting
Board Meeting
March 25th, 2024 2:00 pm
- Date and time: March 25th, 2024 2:00 pm
Public Comment
The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected] no later than the close of business on Wednesday, March 25, 2024, and provide:
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
Written Comment
The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments, concerning this agenda no later than the close of business on Wednesday, March 25, 2024. Please utilize the subject line “March 2024 Board Comments.”
Agenda and Meeting Materials
- Agenda - PDF - 263.92 KB
- Minutes - PDF - 84 KB
- Cost Review Study-Presentation - PDF - 321.67 KB
- Amend COMAR 14.01.02 Fee Assessment Regulations (Amended Text) - PDF - 83.6 KB
- Amend COMAR 14.01.02 Fee Assessment Regulations (Presentation) - PDF - 109.26 KB
- Written Public Comment - PDF - 3.13 MB
The following entities provided written comment in the above attachment:
- Ai Arthritis
- Chronic Disease Coalition
- Committee to Protect Health Care
- Community Access National Network
- Karoll Cortez, MD- GBMC
- Amit “Mickey" Dhir, HIV Specialist
- Dr. Paul Eder
- Gilead
- HIV + HEP Policy Institute
- Infectious Disease Care Center
- Maryland Citizens Health Initiative, Maryland HealthCare for All Coalition
- Maryland Commission on LGBTQIA+ Affair
- Anya Mitchell
- Park West Health System
- Sanofi
- Sinai Hospital of Baltimore